These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16988579)

  • 21. Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
    DeAngelo DJ
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1121-35, vii-viii. PubMed ID: 19825456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
    Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
    Choi J; Foss F
    Yale J Biol Med; 2006 Dec; 79(3-4):169-72. PubMed ID: 17940627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
    Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
    Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
    Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
    Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia].
    Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.
    Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H
    Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
    O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
    Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clofarabine.
    Pui CH; Jeha S
    Nat Rev Drug Discov; 2005 May; Suppl():S12-3. PubMed ID: 15962525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
    Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
    Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clofarabine.
    Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
    Jeha S; Gandhi V; Chan KW; McDonald L; Ramirez I; Madden R; Rytting M; Brandt M; Keating M; Plunkett W; Kantarjian H
    Blood; 2004 Feb; 103(3):784-9. PubMed ID: 14551141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clofarabine for myelodysplastic syndromes.
    Tiu RV; Traina F; Sekeres MA
    Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clofarabine: emerging role in leukemias.
    Sampat K; Kantarjian H; Borthakur G
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nelarabine: new drug. T-lymphoblastic leukaemia/lymphoma: more evaluation needed.
    Prescrire Int; 2009 Feb; 18(99):3-5. PubMed ID: 19382393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.
    Lalayanni C; Baldoumi E; Papayiannopoulos S; Tziola K; Saloum R; Anagnostopoulos A
    Curr Probl Cancer; 2017; 41(2):138-143. PubMed ID: 28169005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.
    Barba P; Sampol A; Calbacho M; Gonzalez J; Serrano J; Martínez-Sánchez P; Fernández P; García-Boyero R; Bueno J; Ribera JM
    Am J Hematol; 2012 Jun; 87(6):631-4. PubMed ID: 22431002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report.
    Gidwani P; Ramesh KH; Liu Y; Kolb EA
    Chemotherapy; 2008; 54(2):120-4. PubMed ID: 18303261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.